WASHINGTON, Jan. 21, 2016 /PRNewswire-USNewswire/ -- Eight years after Congress gave the U.S. Food and Drug Administration (FDA) authority to require Risk Evaluation and Mitigation Strategies (REMS) for higher risk medicines, a new policy paper credits this drug safety system with...